Capacity Planning for Radiopharmaceutical Therapy - Making the Clock an Ally
Radiopharmaceutical therapy capacity isn’t just headcount and rooms—it’s physics. Activity decays by the hour; QC and licensing gates sit on the critical path; hot cells, operators and courier cut‑offs throttle throughput. This post outlines a practical playbook: anchor schedules on patient time, make bottlenecks explicit, separate strategic/tactical/operational horizons, and use finite‑capacity slotting tied to potency windows. Not a sales pitch—just a starting point you can
John Hannan
4 min read
Tracking RAM Licensing Limits - Why “Good Enough” Software Isn’t Good Enough for Radiopharmaceutical Therapy Manufacturing
Radiopharmaceutical therapy manufacturers must track radioactive material (RAM) possession in real time—by nuclide, form, location, and time—to stay within NRC/Agreement State license limits. This post shows where generic ERP fails, what purpose-built RAM tracking must do (decay math, location gates, Part 37 aggregation, 10 CFR 30.51 records), and how to evaluate software and partners.
John Hannan
6 min read
ERP and MES for Radiopharmaceutical Therapy (RPT) Manufacturing - How to Split the Work and Wire It Together Without Regret
RPT manufacturers often need both ERP and MES. This post shows how to split responsibilities—put batch truth and eBR in MES, and commercial/financial truth in ERP—then wire them with event‑based, validated integrations. Learn the boundary for labels, QA release, RAM license gates, and waste; how to avoid double entry and time‑of‑calibration drift; and what to demand in scenario‑based demos. Scale dose‑to‑door without audit risk.
John Hannan
5 min read